Sailila, Kisra H.

HRN: 22-81-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
CEFTRIAXONE 1G (VIAL)
03/29/2023
04/04/2023
IV
2g
Q24H
Mild Traumatic Brain Injury; Lacerated Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: